| Charles Whitaker, MD | |
|
2150 Corbin Ave, New Britain, CT 06053-2298 | |
| (860) 612-6305 | |
| (860) 612-6304 |
| Full Name | Charles Whitaker |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 33 Years |
| Location | 2150 Corbin Ave, New Britain, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942207220 | NPI | - | NPPES |
| 001343871 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 034387 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Constellation Hospice | Orange, CT | Hospice |
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital For Special Care | 7810985637 | 46 |
News Archive
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that Emdeon Clinician™ has been certified to meet Stage 1 Certification Criteria for Meaningful Use of Electronic Health Record (EHR) Technology by the Drummond Group Inc. Emdeon Clinician is a component of Emdeon Office Suite™, which allows healthcare providers to tap into Emdeon's vast network of payers, providers, labs and pharmacies for clinical, financial and administrative healthcare transactions.
South Korea is facing an outbreak of foot and mouth disease reported Seoul's Ministry of Food and Agriculture. Foot and Mouth Disease is a highly contagious and sometimes fatal disease that can affect cloven-hoofed animals including pigs, sheep, cattle, deer and goats. Humans are usually not affected. The three most recent cases take the total number reported in South Korea to 56 with more than 400,000 animals destroyed since November 29.
A protein called CK2 plays a deadly role in colorectal carcinoma by blocking the ability of these tumors to activate a natural self-destruct mechanism that would clear this cancer from the body. This finding, by researchers at St. Jude Children's Research Hospital, is currently published in the online edition of Oncogene.
› Verified 7 days ago
| Entity Name | Hospital For Special Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477534089 PECOS PAC ID: 7810985637 Enrollment ID: O20040506000578 |
News Archive
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that Emdeon Clinician™ has been certified to meet Stage 1 Certification Criteria for Meaningful Use of Electronic Health Record (EHR) Technology by the Drummond Group Inc. Emdeon Clinician is a component of Emdeon Office Suite™, which allows healthcare providers to tap into Emdeon's vast network of payers, providers, labs and pharmacies for clinical, financial and administrative healthcare transactions.
South Korea is facing an outbreak of foot and mouth disease reported Seoul's Ministry of Food and Agriculture. Foot and Mouth Disease is a highly contagious and sometimes fatal disease that can affect cloven-hoofed animals including pigs, sheep, cattle, deer and goats. Humans are usually not affected. The three most recent cases take the total number reported in South Korea to 56 with more than 400,000 animals destroyed since November 29.
A protein called CK2 plays a deadly role in colorectal carcinoma by blocking the ability of these tumors to activate a natural self-destruct mechanism that would clear this cancer from the body. This finding, by researchers at St. Jude Children's Research Hospital, is currently published in the online edition of Oncogene.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Whitaker, MD 2150 Corbin Ave, New Britain, CT 06053-2298 Ph: (860) 612-6305 | Charles Whitaker, MD 2150 Corbin Ave, New Britain, CT 06053-2298 Ph: (860) 612-6305 |
News Archive
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that Emdeon Clinician™ has been certified to meet Stage 1 Certification Criteria for Meaningful Use of Electronic Health Record (EHR) Technology by the Drummond Group Inc. Emdeon Clinician is a component of Emdeon Office Suite™, which allows healthcare providers to tap into Emdeon's vast network of payers, providers, labs and pharmacies for clinical, financial and administrative healthcare transactions.
South Korea is facing an outbreak of foot and mouth disease reported Seoul's Ministry of Food and Agriculture. Foot and Mouth Disease is a highly contagious and sometimes fatal disease that can affect cloven-hoofed animals including pigs, sheep, cattle, deer and goats. Humans are usually not affected. The three most recent cases take the total number reported in South Korea to 56 with more than 400,000 animals destroyed since November 29.
A protein called CK2 plays a deadly role in colorectal carcinoma by blocking the ability of these tumors to activate a natural self-destruct mechanism that would clear this cancer from the body. This finding, by researchers at St. Jude Children's Research Hospital, is currently published in the online edition of Oncogene.
› Verified 7 days ago
Sheila Santhappa, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 608-224-5305 | |
Dr. Michael Balkunas, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, Ondrea Chasse, Medical Staff Office, New Britain, CT 06052 Phone: 860-224-5305 | |
Kevin J Felice, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2150 Corbin Ave, New Britain, CT 06053 Phone: 860-827-4924 | |
Dr. Marc Kawalick, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St, New Britain, CT 06051 Phone: 860-223-3810 | |
Dr. Barry Spass, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 35 Pearl St, New Britain, CT 06051 Phone: 860-223-3810 | |
Dr. Todd Pinter, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 233 Main St, New Britain, CT 06051 Phone: 860-826-1358 Fax: 860-229-8886 | |
Dr. Patricia Aguayo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2150 Corbin Ave, New Britain, CT 06053 Phone: 860-612-6386 |